87891442 - A ANIVIVE

Information

• Trademark
• 87891442

• Source

• Serial Number

  87891442

• Registration Number

  7176344

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  April 24, 2018
  6 years ago

• Registration Date

  September 26, 2023
  a year ago

• Transaction Date

  January 25, 2024
  a year ago

• Status Date

  September 26, 2023
  a year ago

• Published for Opposition Date

  May 19, 2020
  4 years ago

• Location Date

  August 22, 2023
  a year ago

• First Use Anywhere Date

  January 05, 2021
  4 years ago

• First Use In Commerce Date

  January 05, 2021
  4 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  O'BRIEN, JENNIFER LYNN

• Attorney Docket Number

  ALIFE.021T

  Attorney Name

  Ian W. Gillies

  Law Office Assigned Location Code

  N30

• Owners

  • Anivive Lifesciences, Inc.

Case File Statements

• DM0000: The mark consists of dotted "A" with the word "ANIVIVE".
• GS0051: Nutraceuticals for the purpose of treating animal diseases, animal conditions and animal illnesses in the field of veterinary medicine in the nature of autoimmune disorders, oncologic disorders, renal and urinary tract disorders, neurologic disorders, musculoskeletal disorders, infectious disease disorders, dermatologic disorders, ophthalmic disorders, cardiovascular disorders, respiratory disorders, endocrine disorders, metabolic disorders including obesity, gastrointestinal disorders; Pharmaceuticals, namely, pharmaceuticals for the purpose of treating animal diseases, animal conditions and animal illnesses in the field of veterinary medicine in the nature of veterinary pharmaceutical preparations for the treatment of autoimmune disorders, oncologic disorders, renal and urinary tract disorders, neurologic disorders, musculoskeletal disorders, infectious disease disorders, dermatologic disorders, ophthalmic disorders, cardiovascular disorders, respiratory disorders, endocrine disorders, metabolic disorders including obesity, gastrointestinal disorders; Vaccines in the field of veterinary medicine; Therapeutic pharmaceuticals for the purpose of treating animal diseases, animal conditions and animal illnesses in the field of veterinary medicine in the nature of veterinary pharmaceutical preparations for the treatment of autoimmune disorders, oncologic disorders, renal and urinary tract disorders, neurologic disorders, musculoskeletal disorders, infectious disease disorders, dermatologic disorders, ophthalmic disorders, cardiovascular disorders, respiratory disorders, endocrine disorders, metabolic disorders including obesity, gastrointestinal disorders
• CC0000: Color is not claimed as a feature of the mark.
• GS0421: Drug discovery services for veterinary medicine; providing pharmaceutical and medical research services and clinical, medical and scientific research information in the field of animal health; analysis services for veterinary medicine, namely, clinical, medical and scientific research; obtaining, recording, analyzing, reporting and modeling data for animal health purposes, namely, electronic monitoring and reporting of clinical information, namely, age, sex, breed, neuter status, body weight, body condition score, blood pressure, heart rate, frequency and character of respiration, appetite, presence or absence of vomiting, activity level, food and water intake, frequency and character of urination and defecation, of animals, using computers or sensors; platform as a service featuring computer software platforms and providing temporary use of non-downloadable computer software for use in database management, for use as a spreadsheet, for word processing, for statistical analysis, data aggregation, data processing, report generation, data sharing, remote data management, remote project management, and data analysis in the field of veterinary medicine for animal health purposes; platform as a service featuring computer software platforms and providing temporary use of non-downloadable computer software for assisting in drug discovery in the nature of managing clinical trials for animal health purposes; platform as a service featuring computer software platforms and providing temporary use of non-downloadable computer software to facilitate ordering and delivery of medications and treatment to animal owners, distributors and veterinary health care providers for animal health purposes

Case File Event Statements

• 9/26/2023 - a year ago

  65 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC

• 9/26/2023 - a year ago

  64 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 8/23/2023 - a year ago

  63 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA

• 8/22/2023 - a year ago

  62 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR

• 7/31/2023 - a year ago

  61 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC

• 7/14/2023 - a year ago

  60 - USE AMENDMENT FILED Type: IUAF

• 7/14/2023 - a year ago

  59 - TEAS STATEMENT OF USE RECEIVED Type: EISU

• 3/1/2023 - 2 years ago

  58 - ASSIGNED TO EXAMINER Type: DOCK

• 2/8/2023 - 2 years ago

  57 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 2/7/2023 - 2 years ago

  56 - SOU EXTENSION 5 GRANTED Type: EX5G

• 1/11/2023 - 2 years ago

  55 - SOU EXTENSION 5 FILED Type: EXT5

• 1/26/2023 - 2 years ago

  54 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 1/11/2023 - 2 years ago

  53 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 6/21/2022 - 2 years ago

  52 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 6/17/2022 - 2 years ago

  51 - SOU EXTENSION 4 GRANTED Type: EX4G

• 6/17/2022 - 2 years ago

  50 - SOU EXTENSION 4 FILED Type: EXT4

• 6/17/2022 - 2 years ago

  49 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 1/11/2022 - 3 years ago

  48 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 1/7/2022 - 3 years ago

  47 - SOU EXTENSION 3 GRANTED Type: EX3G

• 1/7/2022 - 3 years ago

  46 - SOU EXTENSION 3 FILED Type: EXT3

• 1/7/2022 - 3 years ago

  45 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 7/3/2021 - 3 years ago

  44 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 7/1/2021 - 3 years ago

  43 - SOU EXTENSION 2 GRANTED Type: EX2G

• 7/1/2021 - 3 years ago

  42 - SOU EXTENSION 2 FILED Type: EXT2

• 7/1/2021 - 3 years ago

  41 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 1/9/2021 - 4 years ago

  40 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 1/7/2021 - 4 years ago

  39 - SOU EXTENSION 1 GRANTED Type: EX1G

• 1/7/2021 - 4 years ago

  38 - SOU EXTENSION 1 FILED Type: EXT1

• 1/7/2021 - 4 years ago

  37 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 7/14/2020 - 4 years ago

  36 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 5/19/2020 - 4 years ago

  35 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 5/19/2020 - 4 years ago

  34 - PUBLISHED FOR OPPOSITION Type: PUBO

• 4/29/2020 - 4 years ago

  33 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 4/13/2020 - 4 years ago

  32 - EXPARTE APPEAL TERMINATED Type: EXPT

• 4/13/2020 - 4 years ago

  31 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 4/13/2020 - 4 years ago

  30 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 4/13/2020 - 4 years ago

  29 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 4/13/2020 - 4 years ago

  28 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 4/13/2020 - 4 years ago

  27 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 3/31/2020 - 4 years ago

  26 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 3/31/2020 - 4 years ago

  25 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 3/31/2020 - 4 years ago

  24 - ASSIGNED TO LIE Type: ALIE

• 3/23/2020 - 4 years ago

  23 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR

• 3/23/2020 - 4 years ago

  22 - EX PARTE APPEAL-INSTITUTED Type: EXPI

• 3/23/2020 - 4 years ago

  21 - JURISDICTION RESTORED TO EXAMINING ATTORNEY Type: JURT

• 3/23/2020 - 4 years ago

  20 - EXPARTE APPEAL RECEIVED AT TTAB Type: EXAF

• 9/25/2019 - 5 years ago

  19 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 9/25/2019 - 5 years ago

  18 - FINAL REFUSAL E-MAILED Type: GNFR

• 9/25/2019 - 5 years ago

  17 - FINAL REFUSAL WRITTEN Type: CNFR

• 8/27/2019 - 5 years ago

  16 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 8/26/2019 - 5 years ago

  15 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 8/26/2019 - 5 years ago

  14 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 3/4/2019 - 6 years ago

  13 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 3/4/2019 - 6 years ago

  12 - NON-FINAL ACTION E-MAILED Type: GNRT

• 3/4/2019 - 6 years ago

  11 - NON-FINAL ACTION WRITTEN Type: CNRT

• 2/11/2019 - 6 years ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 2/11/2019 - 6 years ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 2/11/2019 - 6 years ago

  8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 8/16/2018 - 6 years ago

  7 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN

• 8/16/2018 - 6 years ago

  6 - PRIORITY ACTION E-MAILED Type: GPRA

• 8/16/2018 - 6 years ago

  5 - PRIORITY ACTION WRITTEN Type: CPRA

• 8/14/2018 - 6 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 5/4/2018 - 6 years ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 5/3/2018 - 6 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 4/27/2018 - 6 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP